BALAXI PHARMACEUTICALS LIMITED: insider trading, SAST and pledges

No insider-trading filing for this company in the last two years.

FiledAcquirerDirectionModeAcquiredSoldHolding afterPromoter
6 Jun 2025EBISU Global Opportunities Fund Limited
Reg29(2)
Sale Open Market — 500,000
0.91%
4.85% No
2 May 2025EBISU Global Opportunities Fund Limited
Reg29(2)
Sale Open Market — 1,345,891
2.44%
5.75% No
2 May 2025EBISU Global Opportunities Fund Limited
Reg29(1)
Acquisition Open Market 4,521,028
8.18%
— 8.18% No
4 Apr 2025UNICO GLOBAL OPPORTUNITIES FUND LIMITED
Reg29(2)
Sale Open Market — 4,577,717
8.29%
0.00% No
11 Mar 2025MGC Fund Limited
Reg29(2)
Sale Others — 4,650,000
9.50%
0.00% No
6 Mar 2025EBISU Global opportunities fund limited
Reg29(1)
Acquisition Open Market 4,521,028
8.18%
— 8.18% No
5 Mar 2025ELARA INDIA OPPORTUNITIES FUND LIMITED
Reg29(2)
Sale Others — 4,705,248
9.50%
0.00% No
14 Aug 2019Marshal Global Capital Fund Limited
Reg29(1)
Acquisition Preferential Allotment 950,000
9.50%
— 31.25% No
13 Aug 2019Elara India opportunities Fund Ltd
Reg29(1)
Acquisition Preferential Allotment 950,000
9.50%
— 9.50% No
9 Aug 2019Balaxi Overseas Private Ltd
Reg29(2)
Acquisition Preferential Allotment 4,999,964
4.21%
— 70.00% Yes

Showing the most recent disclosures only. Sign in to see more, or upgrade your plan to see the full history. Sign in

Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.